H. Lundbeck A/S (OTCMKTS:HLUYY – Get Free Report)’s stock price was down 0% during mid-day trading on Wednesday. The company traded as low as $22.00 and last traded at $22.00. Approximately 7,500 shares changed hands during mid-day trading, an increase of 327% from the average daily volume of 1,758 shares. The stock had previously closed at $22.0050.
H. Lundbeck A/S Price Performance
The company has a market capitalization of $21.91 billion, a price-to-earnings ratio of 25.00 and a beta of 0.68. The company has a current ratio of 1.15, a quick ratio of 0.71 and a debt-to-equity ratio of 0.32. The company’s 50 day simple moving average is $22.00 and its 200-day simple moving average is $22.00.
About H. Lundbeck A/S
H. Lundbeck A/S is a Denmark-based pharmaceutical company focused on developing and commercializing treatments for disorders of the brain. Its research and product activities primarily address psychiatry and neurology, including depression, schizophrenia, bipolar disorder, migraine, epilepsy and other conditions affecting the central nervous system.
The company’s medicines include Trintellix (vortioxetine) for major depressive disorder, Rexulti (brexpiprazole) for certain psychiatric conditions, Vyepti (eptinezumab) for migraine prevention, and therapies such as Sabril and Onfi for seizure-related disorders.
See Also
- Five stocks we like better than H. Lundbeck A/S
- Alphabet Introduces Gemini Agent—Can It Trigger a Breakout?
- Palantir’s Rally Puts Wall Street in Catch-Up Mode Ahead of November Earnings
- Tilray Finds a Path to Growth Without Waiting on U.S. Cannabis Reform
- Arista Networks Plugs Into All-Time Highs
Receive News & Ratings for H. Lundbeck A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for H. Lundbeck A/S and related companies with MarketBeat.com's FREE daily email newsletter.
